ImmunityBio's findings regarding GBM statistics were related to data provided by the American Brain Tumor Association.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ImmunityBio's findings regarding GBM statistics were related to data provided by the American Brain Tumor Association.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- ImmunityBio announced a study originating from Culver City.Sub-event
ImmunityBio's research findings on GBM statistics are linked to data from the American Brain Tumor Association.1 source
Keep exploring
The entities involved
-
ImmunityBio
biotech company
Nothing else this week.
-
American Brain Tumor Association
non-profit organization in the USA
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireInitial Data Shows 100% Disease Control in 5 Out of 5 Patients With Recurrent Glioblastoma With Two Patients in Near Complete Response Treated With ImmunityBio’s ANKTIVA®, NK Cell Therapy Plus Optune